GSK pairs Wynonna Judd album with Alli

Share this article:

Consumers purchasing GlaxoSmithKline's weight loss drug Alli will receive a free copy of Wynonna Judd's new album Sing, beginning in March.

Two hundred thousand copies of the album will be packaged with select 30-day starter packs and 170-count refill packs of the drug, which is FDA approved and available over the counter.

The deal is the latest incarnation of Judd's ongoing partnership with Alli, which includes TV, print ads and a contest offering a trip for two to Nashville for a private concert.

“In celebration of the start of Wynonna's journey on Alli, we are offering her newest and critically acclaimed album, Sing,” said Rachel Ferdinando, VP, marketing, weight control, at GSK, in a statement. “This program further exhibits the brand's commitment to supporting Wynonna in both her personal and professional journeys, while giving something back to our loyal consumers.”

“I hope that I can inspire people to be better…that they can see themselves in me and say, 'If she can do it, I can do it,'" said Judd in the statement.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.